NEW YORK (GenomeWeb) – Interleukin Genetics this week filed documents with the US Securities and Exchange Commission to complete the process of delisting and deregistering its securities. The Waltham, Massachusetts-based firm announced in late July that it would be liquidating its assets.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.